Systems Analysis of Antigen Presenting Cells in Human Sepsis

NACompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

July 15, 2019

Primary Completion Date

May 23, 2022

Study Completion Date

August 24, 2022

Conditions
SepsisAcute Circulatory Failure
Interventions
OTHER

Multiple blood sampling

ICU septic and non-septic patients will be subjected to repeated blood samples at the following time-points: ICU admission, day 4/5, ICU and hospital discharge, 3 months. Patients exhibiting ICU-acquired infection will also be sampled at the time of diagnosis (up to 6 additional blood samples of 20 mL within 3 months = 120mL)

OTHER

Simple blood sampling

Healthy controls (blood donors and patients undergoing elective cataract surgery) will be subjected to one single blood sample of 20 mL.

Trial Locations (1)

75014

Cochin Hospital, AP-HP, Paris

All Listed Sponsors
collaborator

URC-CIC Paris Descartes Necker Cochin

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03788772 - Systems Analysis of Antigen Presenting Cells in Human Sepsis | Biotech Hunter | Biotech Hunter